Robert Zeiser – REACH3 trial results By Amnon Ron|2021-07-19T11:38:59+00:00July 19th, 2021|All|0 Comments Read More
Alex Lazaryan – Belumosudil’s FDA approval for cGVHD By Amnon Ron|2021-07-19T11:36:45+00:00July 19th, 2021|All|0 Comments Read More
Monzr Al Malki – The role of post cyclophosphamide, for GVHD prophylaxis, in the mismatched unrelated setting By Amnon Ron|2021-07-16T19:20:11+00:00July 16th, 2021|All|0 Comments Read More
Naveen Pemmaraju – Novel Therapeutic Approaches in BPDCN By Amnon Ron|2021-07-16T19:06:20+00:00July 16th, 2021|All|0 Comments Read More
Jurgen Kuball – Gammadelta T cells By Amnon Ron|2021-07-16T19:05:41+00:00July 16th, 2021|All|0 Comments Read More
Anna Sureda – Therapy of lymphomas, what’s new at EHA 2021 By Amnon Ron|2021-07-10T07:23:40+00:00July 10th, 2021|All, EHA 2021|0 Comments Read More
Nitin Jain – Therapy of CLL, what’s new at EHA 2021 By Amnon Ron|2021-07-10T07:20:04+00:00July 10th, 2021|All, EHA 2021|0 Comments Read More
Gram Jackson – Recently released paper on Improving prognostic assignment in older adults with MM By Amnon Ron|2021-07-10T07:11:50+00:00July 10th, 2021|All|0 Comments Read More
Mehdi Hamadani – Recently released ZUMA-7 trial results By Amnon Ron|2021-07-01T12:02:57+00:00July 1st, 2021|All|0 Comments Read More
Saad Usmani – Take-home messages, from ASCO, and EHA 2021 By Amnon Ron|2021-07-01T11:56:33+00:00July 1st, 2021|All|0 Comments Read More
